Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy
- 1 March 1999
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 106 (3), 586-589
- https://doi.org/10.1016/s0161-6420(99)90120-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Neurotoxicity in liver transplant recipients with cyclosporine immunosuppressionNeurology, 1995
- Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behcet's disease involving the nervous system.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's diseaseClinical Rheumatology, 1995
- Clinical study on patients with Behçet's disease in HokkaidoOcular Immunology and Inflammation, 1995
- FK506 Treatment of Noninfectious UveitisAmerican Journal of Ophthalmology, 1994
- A Clinical Trial of FK506 in Refractory UveitisAmerican Journal of Ophthalmology, 1993
- CyclosporinDrugs, 1993
- Therapie der okulären Form des Morbus Behçet mit Cyclosporin AKlinische Monatsblätter für Augenheilkunde, 1990
- DOUBLE-MASKED TRIAL OF CYCLOSPORIN VERSUS COLCHICINE AND LONG-TERM OPEN STUDY OF CYCLOSPORIN IN BEHÇET'S DISEASEThe Lancet, 1989
- CYCLOSPORINE-ASSOCIATED CENTRAL NERVOUS SYSTEM TOXICITY AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1984